INHIBITION OF NEUROGENIC PLASMA EXTRAVASATION BUT NOT VASODILATION IN THE HINDLIMB OF THE RAT BY THE NONPEPTIDE NK-1 RECEPTOR ANTAGONIST (+-)RP67580

被引：0
|
作者：
SHEPHEARD, SL [1 ]
COOK, DA [1 ]
WILLIAMSON, DJ [1 ]
HURLEY, CJ [1 ]
HILL, RG [1 ]
HARGREAVES, RJ [1 ]
机构：
[1] MERCK SHARP & DOHME LTD,NEUROSCI RES CTR,HARLOW CM20 2QR,ESSEX,ENGLAND
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1992年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P150 / P150
页数：1
相关论文
共 50 条
  • [21] ROLE OF NK-1 RECEPTOR IN CENTRAL CARDIOVASCULAR REGULATION IN RATS - STUDIES ON A NOVEL NONPEPTIDE ANTAGONIST, CP-96,345, OF SUBSTANCE-P NK-1 RECEPTOR
    TAKANO, Y
    NAKAYAMA, Y
    TATEISHI, K
    SAITO, R
    KAMIYA, HO
    NEUROSCIENCE LETTERS, 1992, 139 (01) : 122 - 125
  • [22] ROLE OF NK-1 RECEPTOR IN CENTRAL CARDIOVASCULAR REGULATION IN RATS - STUDIES ON A NOVEL NONPEPTIDE ANTAGONIST, CP-96,345, OF SUBSTANCE-P NK-1 RECEPTOR
    SAIGO, A
    TAKANO, Y
    SAITO, R
    NAKAYAMA, Y
    HONDA, K
    KAMIYA, H
    REGULATORY PEPTIDES, 1993, 46 (1-2) : 293 - 296
  • [23] In vitro and in vivo characterization of MDL 105,212A, a nonpeptide NK-1/NK-2 tachykinin receptor antagonist
    Kudlacz, EM
    Shatzer, SA
    Knippenberg, RW
    Logan, DE
    Poirot, M
    VanGiersbergen, PLM
    Burkholder, TP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 277 (02): : 840 - 851
  • [24] INTERACTION OF THE SUBSTANCE-P RECEPTOR ANTAGONIST RP-67580 WITH THE RAT-BRAIN NK1 RECEPTOR EXPRESSED IN TRANSFECTED CHO CELLS
    HERMANS, E
    JEANJEAN, AP
    FARDIN, V
    PRADIER, L
    GARRET, C
    LADURON, PM
    OCTAVE, JN
    MALOTEAUX, JM
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1993, 245 (01): : 43 - 50
  • [25] The tachykinin NK1 receptor antagonist, RP67580, inhibits the bradykinin-induced rise in intracellular Ca2+ concentration in bovine pulmonary artery endothelial cells
    Westra-De Vlieger, JF
    Van den Wijngaard, PWJ
    Koster, AS
    Wilting, J
    Leysen, J
    Van Heuven-Nolsen, D
    Nijkamp, FP
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 342 (2-3) : 359 - 366
  • [26] INVOLVEMENT OF NK-1 RECEPTORS IN NEUROKININ-INDUCED PLASMA EXTRAVASATION (PEV) IN RAT SKIN
    BERESFORD, IJM
    BALSAT, MC
    HAGAN, RM
    JORDAN, CC
    REGULATORY PEPTIDES, 1989, 26 (01) : 60 - 60
  • [27] THE SUSCEPTIBILITY OF AGONIST-EVOKED RESPONSES TO ANTAGONISM BY (+/-) CP96345 AND RP67580 DIFFERS FOR HUMAN AND RAT CLONED NK1 RECEPTORS
    LONGMORE, J
    FONG, TM
    HILL, RG
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U45 - U45
  • [28] Effect of MDL 105,212, a nonpeptide NK-1/NK-2 receptor antagonist in an allergic guinea pig model
    Kudlacz, EM
    Knippenberg, RW
    Logan, DE
    Burkholder, TP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 279 (02): : 732 - 739
  • [29] NK-1, BUT NOT NK-2, TACHYKININ RECEPTORS MEDIATE PLASMA EXTRAVASATION INDUCED BY ANTIDROMIC C-FIBER STIMULATION IN RAT HINDPAW - DEMONSTRATED WITH THE NK-1 ANTAGONIST CP-96,345 AND THE NK-2 ANTAGONIST MEN-10207
    XU, XJ
    DALSGAARD, CJ
    MAGGI, CA
    WIESENFELDHALLIN, Z
    NEUROSCIENCE LETTERS, 1992, 139 (02) : 249 - 252
  • [30] The neurokinin-1 receptor antagonist RP 67580 reduces the sensitization of primary afferents by substance P in the rat
    Pawlak, M
    Schmidt, RF
    Heppelmann, B
    Hanesch, U
    EUROPEAN JOURNAL OF PAIN, 2001, 5 (01) : 69 - 79
12345